Gerald Skipper
Family Medicine · Blountstown, FLNPI 1275507170
Payments from drug & device makers
Across 321 payments — averaging $17.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$858
- Lilly USA, LLC$702
- Boehringer Ingelheim$670
- Novo Nordisk$498
- Amgen$386
- Dexcom, Inc.$331
- plus $2K from 26 others
What the payments were for
- Food & beverage$5,609100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 42 | $858 |
| Lilly USA, LLC | 51 | $702 |
| Boehringer Ingelheim | 27 | $670 |
| Novo Nordisk | 32 | $498 |
| Amgen | 24 | $386 |
| Dexcom, Inc. | 11 | $331 |
| Johnson & Johnson | 23 | $324 |
| Merck | 15 | $244 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $242 |
| GSK | 13 | $200 |
| Pfizer | 11 | $189 |
| Novartis | 9 | $162 |
| AbbVie | 7 | $129 |
| Kowa Pharmaceuticals America, Inc. | 7 | $104 |
| Sanofi-aventis U.S. LLC | 5 | $77 |
| Exact Sciences | 4 | $71 |
| Amarin Pharma, Inc. | 4 | $56 |
| Philips North America LLC | 3 | $52 |
| Astellas Pharma US Inc | 3 | $51 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $46 |
| Melinta Therapeutics, LLC | 2 | $43 |
| Shire North American Group Inc | 2 | $29 |
| Corcept Therapeutics | 1 | $21 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
| Regeneron Healthcare Solutions, Inc. | 1 | $16 |
| Nestle Healthcare Nutrition Inc. | 1 | $16 |
| Bayer | 1 | $16 |
| Ironshore Pharmaceuticals Inc. | 1 | $15 |
| Vivus LLC | 1 | $14 |
| Sanofi Pasteur Inc. | 1 | $14 |
| Corium, LLC | 1 | $12 |
| Avanir Pharmaceuticals, Inc. | 1 | $11 |
How this compares
$5,615 in reported general payments places this provider in the 85th percentile of 7,282 family medicine providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 126 | $88,400 |
| MounjaroTirzepatide | 67 | $75,746 |
| JardianceEmpagliflozin | 86 | $67,281 |
| OzempicSemaglutide | 60 | $59,380 |
| JanuviaSitagliptin Phosphate | 59 | $58,896 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 54 | $43,246 |
| XareltoRivaroxaban | 64 | $40,363 |
| FarxigaDapagliflozin Propanediol | 44 | $31,297 |
| EntrestoSacubitril/Valsartan | 24 | $20,651 |
| TrulicityDulaglutide | 18 | $20,119 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 15 | $14,725 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 27 | $14,012 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 82 | $9,932 |
| LivaloPitavastatin Calcium | 18 | $9,034 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 16 | $7,457 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $702 | $95,86585 claims |
| PfizerEliquis | $189 | $88,400126 claims |
| Boehringer IngelheimJardiance | $670 | $67,28186 claims |
| Novo NordiskOzempic | $498 | $59,38060 claims |
| MerckJanuvia | $244 | $58,89659 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $858 | $51,92183 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $200 | $50,70470 claims |
| Johnson & JohnsonXarelto | $324 | $40,36364 claims |
| NovartisEntresto | $162 | $20,65124 claims |
| Kowa Pharmaceuticals America, Inc.Livalo | $104 | $9,03418 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 7,282 family medicine providers in Florida.
Other family medicine in Blountstown
- Hugh ColemanDaytona Beach$115.5M
- Alexander WhiteDaytona Beach$69.7M
- Ronald SurowitzJupiter$38.3M
- Bruce RankinDeland$36.7M
- Keila HooverMiami$33.7M
- John NardandreaOcala$30.8M
- Jorge CasoMiami$22.6M
- Sharrell CooperPalm Coast$16.9M
- Christopher GallowayMelbourne$15.6M
- Dario AltamiranoHialeah$15.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.